OTCPK:ELTPPharmaceuticals
Elite Pharmaceuticals (OTCPK:ELTP) Profit Turnaround Challenges Bearish Earnings Quality Narratives
Elite Pharmaceuticals (ELTP) just posted its Q3 2026 numbers, with revenue of US$31.6 million, basic EPS of US$0.017, and net income of US$18.6 million, while on a trailing twelve month basis revenue sits at US$140.1 million and EPS at US$0.040. Over the past few quarters, the company has seen revenue move between US$14.4 million and US$40.2 million per quarter, with basic EPS ranging from a loss of US$0.010 to a profit of US$0.018, and trailing twelve month EPS shifting from a loss of...